Fetal Stem Cells

Fetal stem cells carry broad differentiation potential and low immunogenicity. They form the historical core of several European regenerative programmes and remain a defined research area.

At Stem Plus, Fetal Stem Cells are prepared in a GMP-certified laboratory and released from a certified cell bank — characterised, sterile and reproducible for every patient.

How Fetal Stem Cells are used

The therapeutic value of Fetal Stem Cells lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.

Conditions where Fetal Stem Cells feature

Diabetes (Type 1 & 2)Muscular Dystrophy Anemia Male Infertility Primary Immunodeficiency

Quality & safety

GMP-certified preparation in the European Union
Characterised, viability-tested cells from a certified bank
Personalised dosing within a physician-led protocol
Transparent pricing — €3,000–€8,000 per programme

Educational information. Fetal Stem Cells protocols for several conditions remain investigational; outcomes vary by patient.

How Fetal Stem Cells are used

Conditions where Fetal Stem Cells feature

Quality & safety

Explore

Zelltherapie auf EU-Niveau – ohne westeuropäische Preise.